سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

dornier medtech asia pte ltd - general hospital - the fingertip oximeter can be used to measure human haemoglobin saturation and heart rate through finger. the product is suitable for family, hospital (including clinical use in internist/surgery, anaesthesia, paediatrics, intensive sports (it can be used before or after sport. operation in sport is not recommended) and etc. the product is not suitable to monitor patient continuously.

ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

luye pharma (malaysia) sdn. bhd. - quetiapine fumarate -

ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

luye pharma (malaysia) sdn. bhd. - quetiapine fumarate -

ماليزيا - الإنجليزية - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

luye pharma (malaysia) sdn. bhd. - quetiapine fumarate -

تانزانيا - الإنجليزية - Tanzania Medicinces & Medical Devices Authority

crown healthcare (t) ltd, tanzania - centrifuge -

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

nipro asia pte ltd - general hospital - the hypodermic needle is intended to be used with a luer slip or luer lock syringe for aspiration and injection of fluids for medical purpose.

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

nipro asia pte ltd - general hospital - the sterile syringe with needle is intended for use of aspiration and injection of fluids for medical purpose.

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

medico pte ltd - anaesthesiology - the oxygen concentrator is intended for hospitals and homecare to supply oxygen to patients.

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

medico pte ltd - cardiovascular - the finger pulse oximeter is a kind of non-invasive device which can measure and display spo2 and pulse rate. it is intended for adults and children and is expected for home and hospital inspection.

إسرائيل - الإنجليزية - Ministry of Health

bioavenir ltd, israel - fulvestrant - solution for injection - fulvestrant 50 mg/ml - fulvestrant - monotherapy :fulvenir is indicated for the treatment of oestrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:not previously treated with endocrine therapy, or with disease relapse on or after adjuvant endocrine therapy; or disease progression on endocrine therapy. combination therapy with palbociclib: fulvenir is indicated for the treatment of hr-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in combination with palbociclib in women with disease progression after endocrine therapy.